ESRRB p.Pro407Ser
c.1219C>T · rs61742642 · VCV44995
Benign/Likely benign
Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 9 submitters
gnomAD v4.1
Common
common (popmax 13.4%, amr) — too common for a highly-penetrant pathogenic allele
Conditions
1
autosomal recessive nonsyndromic hearing loss 35
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| REVEL | 0.681 | pathogenic-leaning |
|---|---|---|
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 2.2, phastCons 1 |
| Regional constraint | o/e 0.80 | unconstrained · MANE · 122 kb · p 1.3e-06 · regional, not allelic |
| Overall | ||
| CADD | 25.3 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
13.4%
Admixed American · 8,055/59,898 alleles
Filtering AF
13.2%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 13.1%
Overall
7.03%
113,415/1,613,184 alleles · common
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 13.4% | 7 |
| East Asian | 9.67% | 10 |
| Amishnot grpmax-eligible | 7.24% | 14 |
| European (non-Finnish) | 7.07% | 14 |
| Remaining individualsnot grpmax-eligible | 7.04% | 14 |
| South Asian | 6.8% | 15 |
| Ashkenazi Jewishnot grpmax-eligible | 5.58% | 18 |
| Middle Eastern | 5.3% | 19 |
| Finnishnot grpmax-eligible | 5.21% | 19 |
| African / African-American | 2.3% | 43 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ESRRB
- Protein
- p.Pro407Ser
- Coding
- c.1219C>T
- MANE Select
- NM_001379180
- dbSNP
- rs61742642
- Type
- single nucleotide variant
- Location
- chr14:76498312 (GRCh38)
- Gene constraint
- LOEUF 0.56 · pLI 0.79 (gnomAD)
- Structure
- AlphaFold pLDDT 79.14 · 3 PDB
- Residue 407
- the nr lbd domain; an α-helix; the 'essential for esrrb transcriptional activity and interaction with ncoa3' region
Similar variants
- ESRRB c.*1451C>G Likely pathogenic ★★ same condition
- ESRRB c.578-4A>G Uncertain significance ★★ same condition
- ESRRB c.*1502A>T Uncertain significance ★★ same condition
- ESRRB c.*1604G>A Uncertain significance ★★ same condition
- ESRRB c.*2334G>A Uncertain significance ★★ same condition
- ESRRB c.*2382G>A Uncertain significance ★★ same condition
- ESRRB p.Ala101Val Uncertain significance ★★ same condition
- ESRRB p.Arg180His Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/esrrb-p-pro407ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown